ﺳپيرونولاكتون تيڤع ١٠٠ ملغ

Country: Israel

Language: Arabic

Source: Ministry of Health

Buy It Now

Active ingredient:

SPIRONOLACTONE 100 MG

Available from:

TEVA PHARMACEUTICAL INDUST.LTD

ATC code:

C03DA01

Pharmaceutical form:

TABLETS

Administration route:

PER OS

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Therapeutic group:

SPIRONOLACTONE

Therapeutic indications:

Edematous conditions: congestive heart failure; cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. Essential hypertention. Primary hyperaldostronism. Hypokalemia.

Authorization date:

2011-11-01

Documents in other languages

Public Assessment Report Public Assessment Report English 17-08-2016
Patient Information leaflet Patient Information leaflet Hebrew 17-08-2016